Association of Serum Complement C1q and C3 Level with Age-Related Macular Degeneration in Women

References

• Mitchell P, Liew G, Gopinath B, et al. Age-related macular degeneration. Lancet. 2018;392(10153):1147–1159. doi:10.1016/S0140-6736(18)31550-2
   PubMed Web of Science ®Google Scholar
• Wang W, Yan Y, Guo Z, et al. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2021;1:31.
   Google Scholar
• Kauppinen A, Paterno JJ, Blasiak J, et al. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765–1786. doi:10.1007/s00018-016-2147-8
   PubMed Web of Science ®Google Scholar
• Merle NS, Church SE, Fremeaux-Bacchi V, et al. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262. doi:10.3389/fimmu.2015.00262
   PubMed Web of Science ®Google Scholar
• Radu RA, Hu J, Yuan Q, et al. Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J Biol Chem. 2011;286(21):18593–18601. doi:10.1074/jbc.M110.191866
   PubMed Web of Science ®Google Scholar
• Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29(2):95–112. doi:10.1016/j.preteyeres.2009.11.003
   PubMed Web of Science ®Google Scholar
• Demirs JT, Yang J, Crowley MA, et al. Differential and altered spatial distribution of complement expression in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2021;62(7):26. doi:10.1167/iovs.62.7.26
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Sodhi A, Atkinson JP, et al. The role of the immune response in age-related macular degeneration. Int J Inflam. 2013;2013:348092. doi:10.1155/2013/348092
   PubMedGoogle Scholar
• Doyle SL, Campbell M, Ozaki E, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med. 2012;18(5):791–798. doi:10.1038/nm.2717
   PubMed Web of Science ®Google Scholar
• Lechner J, Chen M, Hogg RE, et al. Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: complement activation in AMD. Immun Ageing. 2016;13(1):4. doi:10.1186/s12979-016-0060-5
   PubMed Web of Science ®Google Scholar
• Lynch AM, Mandava N, Patnaik JL, et al. Systemic activation of the complement system in patients with advanced age-related macular degeneration. Eur J Ophthalmol. 2020;30(5):1061–1068. doi:10.1177/1120672119857896
   PubMed Web of Science ®Google Scholar
• Lafon DC, Thiel S, Kim YI, et al. Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults. Immun Ageing. 2020;17(1):18. doi:10.1186/s12979-020-00189-7
   PubMed Web of Science ®Google Scholar
• Horii N, Uchida M, Hasegawa N, et al. Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice. FASEB J. 2018;32:3547–3559. doi:10.1096/fj.201700772RRR
   PubMed Web of Science ®Google Scholar
• Shah D, Romero F, Zhu Y, et al. C1q deficiency promotes pulmonary vascular inflammation and enhances the susceptibility of the lung endothelium to injury. J Biol Chem. 2015;290(49):29642–29651. doi:10.1074/jbc.M115.690784
   PubMed Web of Science ®Google Scholar
• Naito AT, Sumida T, Nomura S, et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell. 2012;149(6):1298–1313. doi:10.1016/j.cell.2012.03.047
   PubMed Web of Science ®Google Scholar
• Stasi K, Nagel D, Yang X, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci. 2006;47(3):1024–1029. doi:10.1167/iovs.05-0830
   PubMed Web of Science ®Google Scholar
• Webster SD, Yang AJ, Margol L, et al. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol. 2000;161(1):127–138. doi:10.1006/exnr.1999.7260
   PubMed Web of Science ®Google Scholar
• Reynolds R, Hartnett ME, Atkinson JP, et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50(12):5818–5827. doi:10.1167/iovs.09-3928
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Adewoyin T, Bailey TA, et al. Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol. 2007;125(4):515–519. doi:10.1001/archopht.125.4.515
   PubMedGoogle Scholar
• Gibson J, Hakobyan S, Cree AJ, et al. Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology. 2012;217(2):251–255. doi:10.1016/j.imbio.2011.07.015
   PubMed Web of Science ®Google Scholar
• Yin C, Ackermann S, Ma Z, et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25(3):496–506. doi:10.1038/s41591-018-0336-8
   PubMed Web of Science ®Google Scholar
• Jiao H, Rutar M, Fernando N, et al. Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration. Mol Neurodegener. 2018;13(1):45. doi:10.1186/s13024-018-0278-0
   PubMed Web of Science ®Google Scholar
• Nitsch D, Douglas I, Smeeth L, et al. Age-related macular degeneration and complement activation-related diseases: a population-based case-control study. Ophthalmology. 2008;115(11):1904–1910. doi:10.1016/j.ophtha.2008.06.035
   PubMed Web of Science ®Google Scholar
• Acosta J, Hettinga J, Flückiger R, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. 2000;97(10):5450–5455. doi:10.1073/pnas.97.10.5450
   PubMed Web of Science ®Google Scholar
• Kreutz R, Schulz A, Sietmann A, et al. Induction of C1q expression in glomerular endothelium in a rat model with arterial hypertension and albuminuria. J Hypertens. 2007;25(11):2308–2316. doi:10.1097/HJH.0b013e3282ef8611
   PubMed Web of Science ®Google Scholar
• Johnson LV, Forest DL, Banna CD, et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2011;108(45):18277–18282. doi:10.1073/pnas.1109703108
   PubMed Web of Science ®Google Scholar
• Yang P, Skiba NP, Tewkesbury GM, et al. Complement-mediated regulation of apolipoprotein e in cultured human rpe cells. Invest Ophthalmol Vis Sci. 2017;58(7):3073–3085. doi:10.1167/iovs.16-20083
   PubMed Web of Science ®Google Scholar
• Chen M, Luo C, Zhao I, et al. Immune regulation in the aging retina. Prog Retin Eye Res. 2019;69:159–172. doi:10.1016/j.preteyeres.2018.10.003
   PubMed Web of Science ®Google Scholar
• Morohoshi K, Goodwin AM, Ohbayashi M, et al. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun. 2009;33(3–4):247–254. doi:10.1016/j.jaut.2009.09.003
   PubMed Web of Science ®Google Scholar
• Atel N, Ohbayashi M, Nugent AK, et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology. 2005;115(3):422–430. doi:10.1111/j.1365-2567.2005.02173.x
   PubMed Web of Science ®Google Scholar
• Matušková V, Zeman T, Ewerlingová L, et al. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population. Acta Ophthalmol. 2020;98(6):e691–e699. doi:10.1111/aos.14357
   PubMed Web of Science ®Google Scholar
• Despriet DD, Van Duijn CM, Oostra BA, et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology. 2009;116(3):474–480. doi:10.1016/j.ophtha.2008.09.055
   PubMed Web of Science ®Google Scholar
• Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357(6):553–561. doi:10.1056/NEJMoa072618
   PubMed Web of Science ®Google Scholar
• Ho E, Cheung C, Sim S, et al. Human pharyngeal microbiota in age-related macular degeneration. PLoS One. 2018;13(8):e201768. doi:10.1371/journal.pone.0201768
   PubMed Web of Science ®Google Scholar
• Javed F, Sculean A, Romanos GE. Association between age-related macular degeneration and periodontal and peri-implant diseases: a systematic review. Acta Ophthalmol. 2021;99(4):351–356. doi:10.1111/aos.14629
   PubMed Web of Science ®Google Scholar
• Robman L, Mahdi O, Mccarty C, et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. Am J Epidemiol. 2005;161(11):1013–1019. doi:10.1093/aje/kwi130
   PubMed Web of Science ®Google Scholar
• Zetterberg M. Age-related eye disease and gender. Maturitas. 2016;83:19–26. doi:10.1016/j.maturitas.2015.10.005
   PubMed Web of Science ®Google Scholar
• Rudnicka AR, Jarrar Z, Wormald R, et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119(3):571–580. doi:10.1016/j.ophtha.2011.09.027
   PubMed Web of Science ®Google Scholar
• Sasaki M, Harada S, Kawasaki Y, et al. Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Sci Rep. 2018;8(1):785. doi:10.1038/s41598-017-18487-4
   PubMed Web of Science ®Google Scholar
• Nuzzi R, Scalabrin S, Becco A, et al. Gonadal hormones and retinal disorders: a review. Front Endocrinol (Lausanne). 2018;9:66. doi:10.3389/fendo.2018.00066
   PubMed Web of Science ®Google Scholar
• Li S, Chen Y, Shao M, et al. Association of plasma complement c3 levels with primary angle-closure glaucoma in older women. Invest Ophthalmol Vis Sci. 2017;58(1):682–689. doi:10.1167/iovs.16-20675
   PubMed Web of Science ®Google Scholar
• Li S, Li D, Shao M, et al. Decreased serum levels of complement c3 reflect complement system dysregulation in patients with primary open-angle glaucoma: results from a pilot study. J Glaucoma. 2018;27(9):761–768. doi:10.1097/IJG.0000000000001014
   PubMed Web of Science ®Google Scholar
• Li S, Zhang H, Shao M, et al. Association between 17-β-estradiol and interleukin-8 and visual field progression in postmenopausal women with primary angle closure glaucoma. Am J Ophthalmol. 2020;217:55–67. doi:10.1016/j.ajo.2020.04.033
   PubMed Web of Science ®Google Scholar
• Cascio C, Deidda I, Russo D, et al. The estrogenic retina: the potential contribution to healthy aging and age-related neurodegenerative diseases of the retina. Steroids. 2015;103:31–41. doi:10.1016/j.steroids.2015.08.002
   PubMed Web of Science ®Google Scholar
• Kaarniranta K, Machalińska A, Veréb Z, et al. Estrogen signalling in the pathogenesis of age-related macular degeneration. Curr Eye Res. 2015;40(2):226–233. doi:10.3109/02713683.2014.925933
   PubMed Web of Science ®Google Scholar
• Monteiro R, Teixeira D, Calhau C. Estrogen signaling in metabolic inflammation. Mediators Inflamm. 2014;2014:615917. doi:10.1155/2014/615917
   PubMed Web of Science ®Google Scholar
• Shepherd R, Cheung AS, Pang K, et al. Sexual dimorphism in innate immunity: the role of sex hormones and epigenetics. Front Immunol. 2020;11:604000. doi:10.3389/fimmu.2020.604000
   PubMed Web of Science ®Google Scholar
• Zhou J, Jang YP, Kim SR, et al. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A. 2006;103(44):16182–16187. doi:10.1073/pnas.0604255103
   PubMed Web of Science ®Google Scholar
• Du X, Yang L, Shujun Z, et al. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid Med Cell Longev. 2021;2021:5523516.
   PubMed Web of Science ®Google Scholar
• Kim SY, Kambhampati SP, Bhutto IA, McLeod DS, Lutty GA, Kannan RM. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model. Exp Eye Res. 2021;203:108391. doi:10.1016/j.exer.2020.108391
   PubMed Web of Science ®Google Scholar
• Liu Y, Lv L. Effect of hormone replacement therapy on serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels in post-menopausal women. J Huazhong Univ Sci Technolog Med Sci. 2008;28(1):102–103. doi:10.1007/s11596-008-0126-5
   PubMedGoogle Scholar
• Yilmazer M, Fenkci V, Fenkci S, et al. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum Reprod. 2003;18(7):1531–1535. doi:10.1093/humrep/deg292
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O, Liskova A, Koklesova L, et al. Caution, “normal” BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J. 2021;12(3):1–22. doi:10.1007/s13167-021-00251-4
   PubMed Web of Science ®Google Scholar
• Li S, Qiu Y, Yu J, et al. Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches. EPMA J. 2021;12(4):1–17.
   PubMed Web of Science ®Google Scholar
• Reddy V, Grogan D, Ahluwalia M, et al. Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA J. 2020;11(2):217–250. doi:10.1007/s13167-020-00203-4
   PubMed Web of Science ®Google Scholar